Major firms forecast to suffer profit loss in third quarter

Published: 2011-10-26 07:00:00

Updated: 2011-10-26 07:00:00

Major Korean pharmaceutical companies are likely to see their third-quarter operating profit worsen, buffeted by tough regulation and their difficulty in reducing promotional expenses, analysts said recently.

According to analysts, Green Cross is expected to post its third quarter earnings wit...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK